Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Quanta, etc...

Re: Quanta, etc...

posted on May 11, 2008 04:48AM
Re: Quanta, etc...

I know we have discussed this before, but I believe TPL's licensing scheme would hold up to scrutiny. Does anyone know if LG charged ongoing royalties on both tiers?

I can't see TPL developing this scheme, which they did for obvious reasons, and then cave to the J's because of it. This would definately affect all future licensing revenues, so why settle and not go to trial if this indeed was the cause of the settlement. I just find it hard to believe. If you only charge the end users with infringment, then the intial infringers are off the hook. If you only charge the manufactures, then they bare the full burden of the whole industry. You can't have your cake and eat it too? ( or can you?)

From TPL site: "The MMP Portfolio Licensing Program therefore focuses licensing requirements and royalty collection on the finished "system-level" product. A royalty-free MMP Portfolio license is also available to manufacturers of chips and other unfinished goods

3
May 11, 2008 04:54AM
Share
New Message
Please login to post a reply